Angiogenic effects of erythropoietin

Domenico Ribatti

Research output: Contribution to journalArticle

Abstract

Erythropoietin (Epo) is a low-molecular weight glycoprotein hormone stimulator of erythropoiesis synthesized in the fetal liver and in the adult kidney. Moreover, Epo is a pleiotropic cytokine that exerts diverse biological effects in non-hematopoietic tissues, and angiogenesis is indicated as one of its extra-hematopoietic functions. The involvement of Epo in angiogenesis may be considered as subset of its role in improving overall tissue oxygenation and of its anti-apoptotic role. In this context, Epo may be considered as an endogenous stimulator of vessel growth during tumor progression, and inhibition of Epo signaling might be suggested as a new antiangiogenic therapeutic approach. It is conceivable suppose that the effect of Epo is multifactorial, depending on the type of tumor and level of functionality of Epo receptor expression in tumor cells, as well as on other variables, such as hypoxic stress and degree of anemia.

Original languageEnglish
Pages (from-to)199-234
Number of pages36
JournalInternational Review of Cell and Molecular Biology
Volume299
DOIs
Publication statusPublished - 2012

Fingerprint

Erythropoietin
Tumors
Tissue
Erythropoietin Receptors
Neoplasms
Oxygenation
Erythropoiesis
Liver
Anemia
Glycoproteins
Molecular Weight
Molecular weight
Cells
Hormones
Cytokines
Kidney
Growth

Keywords

  • Angiogenesis
  • Antiangiogenesis
  • Cardiovascular system
  • Erythropoietin
  • Hypoxia
  • Tumor growth

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Cite this

Angiogenic effects of erythropoietin. / Ribatti, Domenico.

In: International Review of Cell and Molecular Biology, Vol. 299, 2012, p. 199-234.

Research output: Contribution to journalArticle

Ribatti, Domenico. / Angiogenic effects of erythropoietin. In: International Review of Cell and Molecular Biology. 2012 ; Vol. 299. pp. 199-234.
@article{130d4dd1f2a9408283590c3315aa6e33,
title = "Angiogenic effects of erythropoietin",
abstract = "Erythropoietin (Epo) is a low-molecular weight glycoprotein hormone stimulator of erythropoiesis synthesized in the fetal liver and in the adult kidney. Moreover, Epo is a pleiotropic cytokine that exerts diverse biological effects in non-hematopoietic tissues, and angiogenesis is indicated as one of its extra-hematopoietic functions. The involvement of Epo in angiogenesis may be considered as subset of its role in improving overall tissue oxygenation and of its anti-apoptotic role. In this context, Epo may be considered as an endogenous stimulator of vessel growth during tumor progression, and inhibition of Epo signaling might be suggested as a new antiangiogenic therapeutic approach. It is conceivable suppose that the effect of Epo is multifactorial, depending on the type of tumor and level of functionality of Epo receptor expression in tumor cells, as well as on other variables, such as hypoxic stress and degree of anemia.",
keywords = "Angiogenesis, Antiangiogenesis, Cardiovascular system, Erythropoietin, Hypoxia, Tumor growth",
author = "Domenico Ribatti",
year = "2012",
doi = "10.1016/B978-0-12-394310-1.00005-9",
language = "English",
volume = "299",
pages = "199--234",
journal = "International Review of Cell and Molecular Biology",
issn = "1937-6448",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Angiogenic effects of erythropoietin

AU - Ribatti, Domenico

PY - 2012

Y1 - 2012

N2 - Erythropoietin (Epo) is a low-molecular weight glycoprotein hormone stimulator of erythropoiesis synthesized in the fetal liver and in the adult kidney. Moreover, Epo is a pleiotropic cytokine that exerts diverse biological effects in non-hematopoietic tissues, and angiogenesis is indicated as one of its extra-hematopoietic functions. The involvement of Epo in angiogenesis may be considered as subset of its role in improving overall tissue oxygenation and of its anti-apoptotic role. In this context, Epo may be considered as an endogenous stimulator of vessel growth during tumor progression, and inhibition of Epo signaling might be suggested as a new antiangiogenic therapeutic approach. It is conceivable suppose that the effect of Epo is multifactorial, depending on the type of tumor and level of functionality of Epo receptor expression in tumor cells, as well as on other variables, such as hypoxic stress and degree of anemia.

AB - Erythropoietin (Epo) is a low-molecular weight glycoprotein hormone stimulator of erythropoiesis synthesized in the fetal liver and in the adult kidney. Moreover, Epo is a pleiotropic cytokine that exerts diverse biological effects in non-hematopoietic tissues, and angiogenesis is indicated as one of its extra-hematopoietic functions. The involvement of Epo in angiogenesis may be considered as subset of its role in improving overall tissue oxygenation and of its anti-apoptotic role. In this context, Epo may be considered as an endogenous stimulator of vessel growth during tumor progression, and inhibition of Epo signaling might be suggested as a new antiangiogenic therapeutic approach. It is conceivable suppose that the effect of Epo is multifactorial, depending on the type of tumor and level of functionality of Epo receptor expression in tumor cells, as well as on other variables, such as hypoxic stress and degree of anemia.

KW - Angiogenesis

KW - Antiangiogenesis

KW - Cardiovascular system

KW - Erythropoietin

KW - Hypoxia

KW - Tumor growth

UR - http://www.scopus.com/inward/record.url?scp=84865964648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865964648&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-394310-1.00005-9

DO - 10.1016/B978-0-12-394310-1.00005-9

M3 - Article

C2 - 22959304

AN - SCOPUS:84865964648

VL - 299

SP - 199

EP - 234

JO - International Review of Cell and Molecular Biology

JF - International Review of Cell and Molecular Biology

SN - 1937-6448

ER -